Recent Developments in the Treatment of Rheumatoid Arthritis
| Autor: | Susan P. Bruce |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
musculoskeletal diseases
medicine.medical_specialty Ideal (set theory) Biologic response Joint destruction business.industry Abatacept medicine.disease chemistry.chemical_compound Tocilizumab chemistry Rheumatoid arthritis Immunology medicine Pharmacology (medical) Rituximab Intensive care medicine business medicine.drug |
| Zdroj: | Journal of Pharmacy Practice. 22:65-74 |
| ISSN: | 1531-1937 0897-1900 |
| DOI: | 10.1177/0897190008322290 |
| Popis: | The introduction of biologic response modifiers has revolutionized treatment approaches in rheumatoid arthritis. The ideal treatment approach to induce remission and minimize joint destruction is yet to be determined, however. The guidelines for the treatment of rheumatoid arthritis were updated in 2008. Evidence published recently may help to guide treatment decisions. In this review, advances in treatment approaches are discussed with added emphasis on the cardiovascular risks to this patient population. New data regarding the biologic response modifiers currently available in the US, abatacept and rituximab, are reviewed. Finally, emerging therapies are introduced, including tocilizumab. Investigational agents in development may provide additional options in the future treatment of rheumatoid arthritis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|